Drug Profile
Bee venom - Apimeds
Alternative Names: Apitox; Apitoxin; honeybee toxin - Apimeds; purified bee venom - ApimedsLatest Information Update: 11 Oct 2021
Price :
$50
*
At a glance
- Originator Apimeds
- Class Analgesics; Anti-inflammatories; Venoms
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Osteoarthritis
- Phase III Multiple sclerosis
Most Recent Events
- 11 Oct 2021 Bee venom is still in phase III trials for Multiple sclerosis in USA (Intradermal) (Apimeds pipeline, October 2021)
- 11 Oct 2021 Bee venom is still in phase III trials for Osteoarthritis in USA (Intradermal) (Apimeds pipeline, October 2021)
- 11 Oct 2021 Apimeds announces intention to submit BLA to US FDA, in 2024 (Apimeds pipeline, October 2021)